European regulator EMA says it won't set 50% efficacy threshold for COVID shots

Reuters

18 June 2021 - The EMA said on Thursday it would not impose a 50% efficacy threshold for COVID-19 vaccines, adding full trial data was necessary for it to make a sound assessment on the benefits and risks of a shot.

German biotech CureVac said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing its main goal and throwing into doubt the delivery of hundreds of millions of doses to the European Union.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Europe , Regulation , Vaccine , COVID-19